Radiomics of Hepatocellular Carcinoma

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies

NCT06700564 ·Status: NOT_YET_RECRUITING

Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics

NCT05722275 ·Status: RECRUITING

Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data

NCT06533709 ·Status: RECRUITING

Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling

NCT02944006 ·Status: UNKNOWN

Contribution of New Pancreatic MRI Sequences for the Evaluation of Tumor Response in Pancreatic Adenocarcinomas

NCT06842303 ·Status: RECRUITING ·Phase: NA

64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer

NCT05891028 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

NCT05006326 ·Status: UNKNOWN ·Phase: NA

A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma

NCT06148155 ·Status: RECRUITING ·Phase: NA

PET MRI as a Staging Tool for Head and Neck Cancer

NCT04750434 ·Status: COMPLETED

Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

NCT05681234 ·Status: COMPLETED ·Phase: NA

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

NCT03839706 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

NCT04588064 ·Status: COMPLETED ·Phase: NA

CD70-targeted immunoPET Imaging of Kidney Cancer

NCT06680089 ·Status: RECRUITING ·Phase: PHASE2

Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab

NCT06605664 ·Status: RECRUITING ·Phase: PHASE2

Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques

NCT03151564 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

NCT06956144 ·Status: RECRUITING

Target-specific immunoPET Imaging of Digestive System Carcinoma

NCT06715839 ·Status: RECRUITING ·Phase: NA

Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer

NCT03469726 ·Status: UNKNOWN ·Phase: NA

The Function of PET Molecular Imaging Targeting Fibroblast Activation Protein in the Hepatobiliary Malignancies

NCT05264688 ·Status: UNKNOWN

68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

NCT05875753 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors

NCT06182644 ·Status: RECRUITING ·Phase: NA

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

NCT01395030 ·Status: COMPLETED ·Phase: PHASE2

Imaging Correlates of Renal Cell Carcinoma Biological Features

NCT01665703 ·Status: COMPLETED ·Phase: NA

Combined Fluorocholine Positron Emission Tomography and Magnetic Resonance Imaging (FCH-PET/MRI) in Curative Treatment of a Hepatocellular Carcinoma

NCT02824185 ·Status: COMPLETED ·Phase: NA

The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.

NCT02777463 ·Status: COMPLETED